Patients with hereditary hemorrhagic telangiectasia are prone to serious nosebleeds, so many physicians withhold therapy that would normally be administered for serious thrombosis. A survey showed that over 40% had received low-dose aspirin without increased bleeding risk.
No takes yet. Share an insight, caveat, or question.
Devlin et al. (2013) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: